Cargando…

Feasibility and Efficacy of Microwave Ablation Combined with Iodine‐125 Seed Implantation in Local Control of Recurrent Retroperitoneal Liposarcomas: Initial Clinical Experience

INTRODUCTION. The objective of the present study was to evaluate the feasibility, safety, and short‐term efficacy of microwave ablation (MWA) combined with iodine‐125 ((125)I) seed implantation in recurrent retroperitoneal liposarcomas (rRPLs). MATERIALS AND METHODS. From September 2012 to March 201...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Mingjian, Yao, Wang, Zhang, Tao, Fan, Wenzhe, Zhong, Zhihui, Li, Jiaping, Zhang, Fujun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AlphaMed Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728019/
https://www.ncbi.nlm.nih.gov/pubmed/28701568
http://dx.doi.org/10.1634/theoncologist.2016-0499
_version_ 1783285996574474240
author Lu, Mingjian
Yao, Wang
Zhang, Tao
Fan, Wenzhe
Zhong, Zhihui
Li, Jiaping
Zhang, Fujun
author_facet Lu, Mingjian
Yao, Wang
Zhang, Tao
Fan, Wenzhe
Zhong, Zhihui
Li, Jiaping
Zhang, Fujun
author_sort Lu, Mingjian
collection PubMed
description INTRODUCTION. The objective of the present study was to evaluate the feasibility, safety, and short‐term efficacy of microwave ablation (MWA) combined with iodine‐125 ((125)I) seed implantation in recurrent retroperitoneal liposarcomas (rRPLs). MATERIALS AND METHODS. From September 2012 to March 2015, 11 patients were enrolled in this prospective study. Eleven tumors (median, 9 cm; range, 5.5–12.5 cm) were treated with computerized tomography‐guided MWA for 11 sessions and (125)I seed implantation for 18 sessions. (125)I seed implantation was performed 4 weeks after MWA. RESULTS. There were no procedure‐related deaths. Post‐MWA pain (grade ≥2) was the most common complication (6 of 11 patients, 54.5%), and fever (grade ≥2) was observed in two patients. Reversible nerve injury, defined as transient limb paresthesia or leg weakness, was observed in one patient. There were fewer complications associated with the (125)I seed implantation procedure compared with the MWA procedure. All 11 patients who underwent the MWA procedure achieved a partial response (PR), according to the modified Response Evaluation Criteria in Solid Tumors, 1 month post‐ablation; after (125)I seed implantation was performed, a complete response was observed in three, five, and six target tumors in 3, 6, and 12 months, respectively. CONCLUSION. In selected patients with rRPLs, MWA combined with (125)I seed implantation is feasible and safe with favorable local control efficacy. IMPLICATIONS FOR PRACTICE. This study evaluated the feasibility, safety, and short‐term efficacy of microwave ablation (MWA) combined with iodine‐125 ((125)I) seed implantation in recurrent retroperitoneal liposarcomas (rRPLs). Results suggest that a single session of MWA may be not sufficient in large‐volume rRPLs and that as a supplement treatment, (125)I seed implantation is safe and easy accessible. MWA combined with (125)I seed has excellent local control effectiveness, and long‐term efficacy and survival benefit still need to be more comprehensively evaluated.
format Online
Article
Text
id pubmed-5728019
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher AlphaMed Press
record_format MEDLINE/PubMed
spelling pubmed-57280192018-12-01 Feasibility and Efficacy of Microwave Ablation Combined with Iodine‐125 Seed Implantation in Local Control of Recurrent Retroperitoneal Liposarcomas: Initial Clinical Experience Lu, Mingjian Yao, Wang Zhang, Tao Fan, Wenzhe Zhong, Zhihui Li, Jiaping Zhang, Fujun Oncologist Sarcomas INTRODUCTION. The objective of the present study was to evaluate the feasibility, safety, and short‐term efficacy of microwave ablation (MWA) combined with iodine‐125 ((125)I) seed implantation in recurrent retroperitoneal liposarcomas (rRPLs). MATERIALS AND METHODS. From September 2012 to March 2015, 11 patients were enrolled in this prospective study. Eleven tumors (median, 9 cm; range, 5.5–12.5 cm) were treated with computerized tomography‐guided MWA for 11 sessions and (125)I seed implantation for 18 sessions. (125)I seed implantation was performed 4 weeks after MWA. RESULTS. There were no procedure‐related deaths. Post‐MWA pain (grade ≥2) was the most common complication (6 of 11 patients, 54.5%), and fever (grade ≥2) was observed in two patients. Reversible nerve injury, defined as transient limb paresthesia or leg weakness, was observed in one patient. There were fewer complications associated with the (125)I seed implantation procedure compared with the MWA procedure. All 11 patients who underwent the MWA procedure achieved a partial response (PR), according to the modified Response Evaluation Criteria in Solid Tumors, 1 month post‐ablation; after (125)I seed implantation was performed, a complete response was observed in three, five, and six target tumors in 3, 6, and 12 months, respectively. CONCLUSION. In selected patients with rRPLs, MWA combined with (125)I seed implantation is feasible and safe with favorable local control efficacy. IMPLICATIONS FOR PRACTICE. This study evaluated the feasibility, safety, and short‐term efficacy of microwave ablation (MWA) combined with iodine‐125 ((125)I) seed implantation in recurrent retroperitoneal liposarcomas (rRPLs). Results suggest that a single session of MWA may be not sufficient in large‐volume rRPLs and that as a supplement treatment, (125)I seed implantation is safe and easy accessible. MWA combined with (125)I seed has excellent local control effectiveness, and long‐term efficacy and survival benefit still need to be more comprehensively evaluated. AlphaMed Press 2017-07-12 2017-12 /pmc/articles/PMC5728019/ /pubmed/28701568 http://dx.doi.org/10.1634/theoncologist.2016-0499 Text en © 2017 The Authors. The Oncologist published by Wiley Periodicals, Inc. on behalf of AlphaMed Press http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Sarcomas
Lu, Mingjian
Yao, Wang
Zhang, Tao
Fan, Wenzhe
Zhong, Zhihui
Li, Jiaping
Zhang, Fujun
Feasibility and Efficacy of Microwave Ablation Combined with Iodine‐125 Seed Implantation in Local Control of Recurrent Retroperitoneal Liposarcomas: Initial Clinical Experience
title Feasibility and Efficacy of Microwave Ablation Combined with Iodine‐125 Seed Implantation in Local Control of Recurrent Retroperitoneal Liposarcomas: Initial Clinical Experience
title_full Feasibility and Efficacy of Microwave Ablation Combined with Iodine‐125 Seed Implantation in Local Control of Recurrent Retroperitoneal Liposarcomas: Initial Clinical Experience
title_fullStr Feasibility and Efficacy of Microwave Ablation Combined with Iodine‐125 Seed Implantation in Local Control of Recurrent Retroperitoneal Liposarcomas: Initial Clinical Experience
title_full_unstemmed Feasibility and Efficacy of Microwave Ablation Combined with Iodine‐125 Seed Implantation in Local Control of Recurrent Retroperitoneal Liposarcomas: Initial Clinical Experience
title_short Feasibility and Efficacy of Microwave Ablation Combined with Iodine‐125 Seed Implantation in Local Control of Recurrent Retroperitoneal Liposarcomas: Initial Clinical Experience
title_sort feasibility and efficacy of microwave ablation combined with iodine‐125 seed implantation in local control of recurrent retroperitoneal liposarcomas: initial clinical experience
topic Sarcomas
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728019/
https://www.ncbi.nlm.nih.gov/pubmed/28701568
http://dx.doi.org/10.1634/theoncologist.2016-0499
work_keys_str_mv AT lumingjian feasibilityandefficacyofmicrowaveablationcombinedwithiodine125seedimplantationinlocalcontrolofrecurrentretroperitonealliposarcomasinitialclinicalexperience
AT yaowang feasibilityandefficacyofmicrowaveablationcombinedwithiodine125seedimplantationinlocalcontrolofrecurrentretroperitonealliposarcomasinitialclinicalexperience
AT zhangtao feasibilityandefficacyofmicrowaveablationcombinedwithiodine125seedimplantationinlocalcontrolofrecurrentretroperitonealliposarcomasinitialclinicalexperience
AT fanwenzhe feasibilityandefficacyofmicrowaveablationcombinedwithiodine125seedimplantationinlocalcontrolofrecurrentretroperitonealliposarcomasinitialclinicalexperience
AT zhongzhihui feasibilityandefficacyofmicrowaveablationcombinedwithiodine125seedimplantationinlocalcontrolofrecurrentretroperitonealliposarcomasinitialclinicalexperience
AT lijiaping feasibilityandefficacyofmicrowaveablationcombinedwithiodine125seedimplantationinlocalcontrolofrecurrentretroperitonealliposarcomasinitialclinicalexperience
AT zhangfujun feasibilityandefficacyofmicrowaveablationcombinedwithiodine125seedimplantationinlocalcontrolofrecurrentretroperitonealliposarcomasinitialclinicalexperience